h.karlsen
TL2 · Córdoba
Contributes reviews on supplier material. Based in Córdoba.
Joined 19 March 2025 · last posted 7d
77 posts, newest first. Showing up to 150.
-
What is genuinely unknown about long-term amylin agonism Replied, post #64 · Compounds › Cagrilintide & amylin analogues · 21 Jul 2026 · 21 likes Everything in post #60 holds. The case it does not cover is the one I have. Nausea profile of amylin analogues: the historical agent pramlintide required multiple daily…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #29 · Compounds › Repair & healing peptides · 13 Jul 2026 · 0 likes Answering the question post #25 raises rather than the one it answers. What would change the position on repair peptides: adequately powered, published, peer-reviewed…
-
Reading a home test result without over-claiming Replied, post #112 · Analytics › Home & field testing · 9 Jul 2026 · 0 likes Taking post #111 at face value and following it one step further. Reconstitution behaviour is a legitimate home observation. A cake that will not dissolve, a solution…
-
Asking a follow-up: new topic or new reply? Replied, post #42 · Start Here › How to Ask · 7 Jul 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. The claim is narrower than it sounds,…
-
Designing a personal experiment that could change your mind — one year on Replied, post #67 · Research Methods › N-of-1 designs · 28 Jun 2026 · 16 likes It does not tell you about anybody else, which is why aggregating these accounts does not produce evidence of the kind people want it to. I would put this at better…
-
Reading a home test result without over-claiming Replied, post #87 · Analytics › Home & field testing · 20 Jun 2026 · 22 likes A control sample of known material run alongside is what turns a home test from an impression into a comparison. Without one you are calibrating against memory. Small…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #28 · Access › Insurance & coverage · 19 Jun 2026 · 9 likes A clinician's supporting letter that addresses the criteria explicitly is worth considerably more than one that describes the patient generally. The short version is…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #52 · Analytics › Home & field testing · 18 Jun 2026 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Racemisation and why it is invisible to a mass measurement Replied, post #91 · Analytics › Impurities & related substances · 13 Jun 2026 · 0 likes Taking racemisation seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and those…
-
Micronutrient adequacy at low total intake Replied, post #57 · Nutrition & Training › Protein & intake · 11 Jun 2026 · 15 likes Adding the measurement that post #56 says would settle it. Fibre and fluid tend to fall alongside protein when intake drops, and the constipation reported here follows…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #82 · Evidence › Journal club · 10 Jun 2026 · 24 likes The arithmetic in post #79 is right; the assumption feeding it is the part to check. Where the group cannot agree, record the disagreement rather than resolving it by…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #26 · Evidence › Journal club · 10 Jun 2026 · 7 likes That is the distinction I keep failing to hold on to. Written down now.
-
Labelling requirements for research chemicals — the long version Replied, post #3 · Sourcing › Regulatory · 6 Jun 2026 · 1 like Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Journal club: LEADER as the historical anchor Replied, post #82 · Evidence › Journal club · 31 May 2026 · 0 likes Second-hand on LEADER, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Revisiting: What pooling buys you and what it destroys Replied, post #31 · Evidence › Meta-analyses · 23 May 2026 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
-
Talking to a therapist about this specifically Replied, post #6 · marked as the solution · Wellbeing › Mental health · 19 May 2026 · 28 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #104 · Devices › Syringes & needles · 10 May 2026 · 19 likes This follows post #103 rather than contradicting it. The most useful thing anyone has posted about 0.3 ml versus 0.5 ml in this category was a table of what had been…
-
Journal club: is percentage weight change the right endpoint? Replied, post #94 · Evidence › Journal club · 22 Apr 2026 · 15 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
[2026 update] Composite endpoints and the component doing the work Replied, post #69 · Evidence › Trials · 14 Apr 2026 · 0 likes The strongest argument against my own position on Composite endpoints, stated as well as I can state it, since nobody else has yet.
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #92 · Sourcing › Vendor reports · 9 Apr 2026 · 13 likes Answering the question post #90 raises rather than the one it answers. Photograph the vial and the label before opening. It costs ten seconds and it is what turns a…
-
List price versus negotiated price versus what you pay Replied, post #8 · Access › Pricing · 8 Apr 2026 · 20 likes Summarising the list price versus negotiated price thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the…
-
Citation sweep results: how many references did not say what was claimed Replied, post #71 · Meta › Wiki maintenance · 3 Apr 2026 · 0 likes That matches how I use it. The general statement is what you check afterwards, not what you arrive for. That distinction has done more work for me than anything else in…
-
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #2 · Pharmacology › Pharmacokinetics · 31 Mar 2026 · 0 likes Answering the question the opening post raises rather than the one it answers. Where the Half-life discussion usually stalls is that nobody wants to say "I do not know"…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #75 · Practice › Reconstitution · 26 Mar 2026 · 8 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
How to ask about something you suspect is a bad idea Replied, post #68 · Start Here › How to Ask · 23 Mar 2026 · 1 like A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #149 · Access › International · 7 Mar 2026 · 3 likes Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting decoratively at the end. Written quickly, so the reasoning may…
-
Managing an unplanned gap in supply Replied, post #41 · Access › Shortages · 24 Feb 2026 · 12 likes Coming back to post #37, because the follow-up matters more than the original answer. Small correction to my own earlier position on managing an unplanned gap. I had…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #12 · Compounds › Oral incretins · 5 Feb 2026 · 12 likes Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a functioning absorption-enhancement system at all. The formulation…
-
Five questions in one post gets you one answer — how to split them Replied, post #2 · Start Here › How to Ask · 23 Jan 2026 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Asking a follow-up: new topic or reply in the old one? If the answer depends on the…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #29 · Data & Tools › Calculators · 23 Jan 2026 · 0 likes Significant figures in the output should not exceed what the inputs support. A concentration calculated from a nominal vial mass is not known to four decimal places.
-
What to include when your question involves a chromatogram Replied, post #54 · Start Here › How to Ask · 18 Jan 2026 · 6 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
-
Moderation log format change Replied, post #22 · Meta › Announcements · 18 Jan 2026 · 2 likes Reading this moderation log format change thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Reading an interaction checker output critically Replied, post #82 · Practice › Interactions · 3 Jan 2026 · 18 likes Thank you for the correction. I would rather find out here than later.
-
Prescription requirements and telehealth models Replied, post #69 · Sourcing › Regulatory · 15 Dec 2025 · 30 likes An indication approved for one age range does not extend to another, and paediatric extensions are separate decisions with separate evidence.
-
Tracking a preprint to publication: a worked example Replied, post #134 · Evidence › Preprints · 13 Dec 2025 · 19 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
Availability by country, dated, with primary sources — one year on Replied, post #5 · Access › International · 8 Dec 2025 · 0 likes Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page about it, including this one. Not the whole picture,…
-
Robustness: the parameters worth deliberately varying Replied, post #30 · Analytics › Method validation · 30 Nov 2025 · 0 likes Worth separating robustness as a question about the compound from robustness as a question about the documentation. They get answered by different people and only one…
-
The headache that turns out to be dehydration Replied, post #57 · Nutrition & Training › Hydration & electrolytes · 15 Nov 2025 · 0 likes Taking post #54 at face value and following it one step further. Since headache keeps coming up, it should probably be a maintained page rather than a recurring thread.…
-
New subcategory: rationale and scope Replied, post #122 · Meta › Announcements · 25 Oct 2025 · 5 likes The arithmetic on new subcategory is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
-
Managing an unplanned gap in supply — what changed since Replied, post #96 · Access › Shortages · 24 Oct 2025 · 8 likes Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum…
-
Run-in periods and the population they select Replied, post #12 · Evidence › Trials · 20 Oct 2025 · 0 likes Two things can be true about run-in periods at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is people…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #64 · Practice › Storage & stability · 20 Sep 2025 · 2 likes I read post #61 twice before replying, because I had assumed the opposite. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #22 · Compounds › Tirzepatide · 17 Sep 2025 · 0 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #38 · Compounds › Repair & healing peptides · 2 Sep 2025 · 9 likes Post #36 describes the usual case. This is about the unusual one. Two questions I would want answered before drawing anything from the BPC-157 data above: how were the…
-
Revisiting: List price versus negotiated price versus what you pay Replied, post #15 · Access › Pricing · 7 Aug 2025 · 1 like Whatever the answer on List price versus negotiated price turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public,…
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #70 · Compounds › Oral incretins · 25 Jul 2025 · 11 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #20 · Compounds › Repair & healing peptides · 22 May 2025 · 3 likes On TB-500 and thymosin beta-4, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is…
-
Washout: how long is long enough, and for what purpose Replied, post #28 · Pharmacology › Pharmacokinetics · 21 May 2025 · 24 likes Thank you for taking the time. That was more work than a reply usually is.
-
Triple agonism: additive, synergistic, or neither? Replied, post #48 · Compounds › Retatrutide · 20 May 2025 · 7 likes Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
When to stop reading forums, including this one — the long version Replied, post #16 · Wellbeing › Mental health · 12 May 2025 · 0 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant. I…
-
Requesting a page: what makes a good request Replied, post #69 · Documentation › Wiki requests · 24 Apr 2025 · 1 like Where I part company with post #65, and it is a narrow parting. Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is…
-
Sequence verification for an obscure compound: how it is done Replied, post #16 · Compounds › Other compounds · 20 Apr 2025 · 26 likes The failure mode on sequence verification is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to…
-
A supplier that answers analytical questions with restated claims Replied, post #60 · Sourcing › Red flags · 19 Apr 2025 · 19 likes That is a fair summary of where the discussion has got to.
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #55 · Evidence › Journal club · 9 Apr 2025 · 4 likes Thank you for taking the time. That was more work than a reply usually is.
-
Certificates issued by the seller versus by a laboratory Replied, post #19 · Analytics › COA interpretation · 26 Mar 2025 · 0 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #43 · Access › Insurance & coverage · 26 Mar 2025 · 0 likes Coverage is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Second pass at: A single out-of-range value on an otherwise normal panel Replied, post #12 · Clinical › Bloodwork · 23 Mar 2025 · 0 likes Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Adjudicated events and why the definition matters — the long version Replied, post #52 · Evidence › Trials · 17 Mar 2025 · 0 likes Post #48 describes the usual case. This is about the unusual one. Where the Adjudicated events discussion usually stalls is that nobody wants to say "I do not know" and…
-
Revisiting: Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #8 · Practice › Administration · 17 Mar 2025 · 1 like If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. Adding…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #18 · Pharmacology › Receptor biology · 27 Feb 2025 · 3 likes Right, and stated more narrowly than I would have dared to state it.
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #25 · Documentation › Doc review · 17 Feb 2025 · 4 likes Draft on reconstitution arithmetic came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #48 · Access › International · 16 Feb 2025 · 0 likes Answering the question post #46 raises rather than the one it answers. Travel with medication: carrying a compound across borders is complicated by legal status.…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #56 · Compounds › Secretagogues & GH axis · 28 Jan 2025 · 14 likes This follows post #55 rather than contradicting it. Injection-site reactions are reported more often in this family than for the incretins. Whether that is the…
-
What changed in 2026, by region Replied, post #95 · Access › International · 23 Jan 2025 · 0 likes Noted, and thank you for writing it out rather than summarising it.
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #37 · Compounds › Secretagogues & GH axis · 19 Jan 2025 · 18 likes Building on post #34 rather than restating it. Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #84 · Compounds › Tirzepatide · 20 Dec 2024 · 8 likes Confirming post #81 from a second method, which matters more than confirming it from a second person. SURPASS-2 has a well-known answer and a correct answer, and the…
-
Converting between mg/mL and units per dose, both directions Replied, post #127 · Practice › Reconstitution · 12 Dec 2024 · 30 likes Dead volume is the part nobody mentions until it costs them a dose. A fixed-needle insulin syringe holds very little; a detachable-needle luer configuration can hold…
-
Telehealth prescribing models in the US Replied, post #32 · Regional › North America · 11 Dec 2024 · 0 likes Reading this telehealth prescribing models thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Two sessions a week versus four: what the evidence supports Replied, post #16 · Nutrition & Training › Resistance training · 27 Nov 2024 · 16 likes Thank you for the correction. I would rather find out here than later.
-
Athletes in weight-category sports: a different risk calculus — a second dataset Replied, post #24 · Clinical › Special populations · 22 Nov 2024 · 0 likes Noted, and thank you for writing it out rather than summarising it.
-
US compounding rules and how they changed Replied, post #12 · Regional › North America · 5 Oct 2024 · 0 likes Coming back to post #10, because the follow-up matters more than the original answer. Cross-border purchasing raises both a legal question and a practical one, and the…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #50 · Compounds › Retatrutide · 21 Sep 2024 · 10 likes The claim about hepatic effects of glucagon receptor upthread is stronger than its source supports. I have read the source. The source says "associated with" and the…
-
Converting between mg/mL and units per dose, both directions Replied, post #12 · Practice › Reconstitution · 6 Sep 2024 · 27 likes Confirming post #9 from a second method, which matters more than confirming it from a second person. The best check on any reconstitution calculation is to do it twice…
-
Air bubbles in a subcutaneous injection: the honest risk assessment Replied, post #2 · Practice › Administration · 10 Aug 2024 · 27 likes Building on the opening post rather than restating it. Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is…
-
How this community labels and discusses unrefereed work Replied, post #72 · Evidence › Preprints · 9 Jul 2024 · 15 likes My understanding of community labels is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
Why I ask for the gradient before I discuss the number Replied, post #5 · Analytics › HPLC & UHPLC · 4 Jul 2024 · 3 likes Post #4 describes the usual case. This is about the unusual one. A chromatogram image at a resolution where you can see peak shape but not baseline detail is worth…
-
Spreadsheets: an appreciation Replied, post #8 · Lounge › Off topic · 5 Jun 2024 · 0 likes Second-hand on spreadsheets, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.